Department of Infectious Diseases, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Epidemiol Infect. 2020 Aug 28;148:e196. doi: 10.1017/S095026882000196X.
During the coronavirus disease 2019 (COVID-19) pandemic, a new phenomenon manifesting as a multisystem inflammatory syndrome in children (MIS-C) which has a similar clinical presentation to Kawasaki disease, toxic shock syndrome and severe sepsis has emerged. Although the number of MIS-C reports is increasing, rare reports in Asia is still available. To our knowledge, this study is the largest series of published MIS-C cases in Iran. We performed a retrospective study of all patients with case definition for MIS-C admitted to the three paediatric hospitals in Iran. All of these hospitals are located within the most active COVID-19 pandemic areas (Tehran, Qom and Mazandaran) in Iran. Demographic characteristics, clinical data, laboratory findings, imaging and echocardiographic findings, treatment and outcomes were collected. Between 7 March and 23 June 2020, 45 children were included in the study. The median age of children was 7 years (range between 10 months and 17 years). Common presenting symptoms include fever (91%), abdominal pain (58%), nausea/vomiting (51%), mucocutaneous rash (53%), conjunctivitis (51%) and hands and feet oedema (40%) with median duration of symptoms prior to presentation of 5 (interquartile range (IQR) 3, 7) days. Fifty-three percent of children showed lymphopaenia. Overall, the majority of cases at admission had markedly elevated inflammatory markers erythrocyte sedimentation rate (ESR) (95.5%) and C-reactive protein (CRP) (97%). Ferritin was abnormal in 11 out of 14 tested patients (73%), and it was highly elevated (>500 ng/ml) in 47% of cases. Median fibrinogen level was 210 (IQR 165, 291) mg/dl, D-dimer was 3909 (IQR 848, 4528) ng/ml and troponin was 0.6 (IQR 0.1, 26) ng/ml, respectively. Twenty out of 31 patients (64.5%) had hypoalbuminaemia. In addition, hyponatraemia was found in 64% of cases. Twenty-five patients (56%) presented with cardiac involvement and acute renal failure was observed in 13 cases (29%). Pleural, ascitic, ileitis and pericardial effusions were found in 18%, 11%, 4% and 2% of cases, respectively. In conclusion, this is a first large case series of hospitalised children who met criteria for MIS-C in Iran. There was a wide spectrum of presenting signs and symptoms; evidence of inflammation with abnormal values of CRP, ESR, D-dimer, ferritin and albumin; and multi-organ involvement.
在 2019 年冠状病毒病(COVID-19)大流行期间,一种新的现象表现为儿童多系统炎症综合征(MIS-C),其临床表现与川崎病、中毒性休克综合征和严重败血症相似。尽管 MIS-C 的报告数量正在增加,但亚洲的罕见报告仍然存在。据我们所知,这项研究是伊朗发表的最大系列 MIS-C 病例。我们对伊朗三家儿科医院收治的符合 MIS-C 病例定义的所有患者进行了回顾性研究。这些医院都位于伊朗 COVID-19 大流行最活跃的地区(德黑兰、库姆和马赞达兰)。收集了人口统计学特征、临床数据、实验室检查结果、影像学和超声心动图结果、治疗和结局。2020 年 3 月 7 日至 6 月 23 日期间,共有 45 名儿童纳入研究。儿童的中位年龄为 7 岁(年龄在 10 个月至 17 岁之间)。常见的首发症状包括发热(91%)、腹痛(58%)、恶心/呕吐(51%)、黏膜皮肤疹(53%)、结膜炎(51%)和手足水肿(40%),就诊前症状中位持续时间为 5 天(四分位间距(IQR)3、7)。53%的患儿出现淋巴细胞减少症。总体而言,大多数入院病例的炎症标志物红细胞沉降率(ESR)(95.5%)和 C 反应蛋白(CRP)(97%)显著升高。14 例检测患者中有 11 例(73%)铁蛋白异常,其中 47%的病例铁蛋白高度升高(>500ng/ml)。中位纤维蛋白原水平为 210(IQR 165、291)mg/dl,D-二聚体为 3909(IQR 848、4528)ng/ml,肌钙蛋白为 0.6(IQR 0.1、26)ng/ml。31 例患者中有 20 例(64.5%)存在低白蛋白血症。此外,64%的病例存在低钠血症。25 例(56%)患者出现心脏受累,13 例(29%)患者出现急性肾衰竭。胸腔积液、腹水、回肠炎和心包积液分别见于 18%、11%、4%和 2%的病例。总之,这是伊朗首例符合 MIS-C 标准的住院儿童大病例系列。临床表现多样,包括炎症标志物 CRP、ESR、D-二聚体、铁蛋白和白蛋白异常;以及多器官受累。